Scientific article
English

Sphingolipids and membrane targets for therapeutics

Published in

Current Opinion in Chemical Biology, vol. 50, p. 19-28

Publication date

2019

Abstract

Lipids and membranes are often strongly altered in various diseases and pathologies, but are not often targeted for therapeutic advantage. In particular, the sphingolipids are particularly sensitive to altered physiology and have been implicated as important players in not only several rare hereditary diseases, but also other major pathologies, including cancer. This review discusses some potential targets in the sphingolipid pathway and describes how the initial drug compounds have been evolved to create potentially improved therapeutics. This reveals how lipids and their interactions with proteins can be used for therapeutic advantage. We also discuss the possibility that modification of the physical properties of membranes could also affect intracellular signaling and be of therapeutic interest.

Citation (ISO format)

LOEWITH, Robbie Joséph, RIEZMAN, Howard, WINSSINGER, Nicolas. Sphingolipids and membrane targets for therapeutics. In: Current Opinion in Chemical Biology, 2019, vol. 50, p. 19–28. doi: 10.1016/j.cbpa.2019.02.015

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1367-5931
573views
3downloads

Technical informations

Creation

21/03/2019 13:26:00

First validation

21/03/2019 13:26:00

Update

13/10/2025 18:25:34

Status update

15/03/2023 16:00:59

Last indexation

01/07/2026 06:11:17
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated